MedTrace Logo

Stockholm hyperTRIglyceridemia REGister (STRIREG) Study

NCT06104943 · Status: ACTIVE_NOT_RECRUITING · Type: OBSERVATIONAL · Enrollment: 3607819

Last updated 2023-10-27

No results posted yet for this study

Summary

The STRIREG study is a retrospective longitudinal general population-based register study including all individuals who had had at least one plasma Tg measurement between 1st January 2000 and 31st December 2021 at Karolinska University Laboratory or Unilabs AB in Region Stockholm (population 2.41 million 2021). The exclusion criteria were a lack of a unique Swedish personal identification number (PIN). The index population consisted of 1,460,184 individuals between the age 0 and 107 years. The index population was extended to form the complete cohort (n=3,607,819) by associating the parents and the siblings (n=2,147,635) to the indexes by interlinkage of personal identification numbers via the Multi-Generation register (see below).

The study baseline for the index population was defined as the date for participant's first Tg measurement.

Conditions

  • Familial Hypertriglyceridemia

Interventions

OTHER

Heredity for cardiovascular disease

First degree relatives with a diagnosis of Cardiovascular disease.

OTHER

Heredity for pancreatitis

First degree relatives with a diagnosis of pancreatitis.

OTHER

Heredity for type 2 diabetes

First degree relatives with a diagnosis of type 2 diabetes.

OTHER

Heredity for hypertriglyceridemia

First degree relatives with hypertriglyceridemia

Sponsors & Collaborators

  • Region Stockholm

    lead OTHER_GOV

Eligibility

Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2000-01-01
Primary Completion
2021-12-31
Completion
2027-12-31

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06104943 on ClinicalTrials.gov